Integral Diagnostics Limited
ITGDF
$2.06
$0.687450.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 324.08M | 317.04M | 308.04M | 304.64M | 303.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 324.08M | 317.04M | 308.04M | 304.64M | 303.15M |
| Cost of Revenue | 221.79M | 215.94M | 208.72M | 206.52M | 205.61M |
| Gross Profit | 102.28M | 101.10M | 99.32M | 98.12M | 97.54M |
| SG&A Expenses | 18.31M | 18.01M | 17.60M | 17.35M | 17.20M |
| Depreciation & Amortization | 31.36M | 31.14M | 30.73M | 30.21M | 29.87M |
| Other Operating Expenses | 8.85M | 8.91M | 8.88M | 9.50M | 10.15M |
| Total Operating Expenses | 295.96M | 289.26M | 280.74M | 277.62M | 276.23M |
| Operating Income | 28.11M | 27.79M | 27.30M | 27.02M | 26.92M |
| Income Before Tax | 5.94M | -15.62M | -37.28M | -36.07M | -34.75M |
| Income Tax Expenses | 2.21M | 2.28M | 2.34M | 2.58M | 2.84M |
| Earnings from Continuing Operations | 3.73 | -17.90 | -39.62 | -38.64 | -37.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.73M | -17.90M | -39.62M | -38.64M | -37.59M |
| EBIT | 28.11M | 27.79M | 27.30M | 27.02M | 26.92M |
| EBITDA | 47.72M | 47.28M | 46.57M | 46.10M | 45.93M |
| EPS Basic | 0.02 | -0.08 | -0.17 | -0.17 | -0.16 |
| Normalized Basic EPS | 0.03 | 0.03 | 0.04 | 0.02 | 0.01 |
| EPS Diluted | 0.01 | -0.08 | -0.17 | -0.17 | -0.16 |
| Normalized Diluted EPS | 0.03 | 0.03 | 0.04 | 0.02 | 0.01 |
| Average Basic Shares Outstanding | 962.49M | 948.24M | 933.99M | 933.16M | 932.33M |
| Average Diluted Shares Outstanding | 973.82M | 959.57M | 945.32M | 941.92M | 938.53M |
| Dividend Per Share | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Payout Ratio | 244.84% | -50.96% | -22.87% | -23.30% | -23.93% |